MYC/BCL2/BCL6 triple hit lymphoma of the pericardium: a case report and review of the literature.
作者信息
Efstathopoulou A, Ghielmini M, Zucca E
机构信息
Medical Oncology Clinic, Oncology Institute of Southern Switzerland, 6500, Bellinzona, Switzerland.
出版信息
J Cancer Res Clin Oncol. 2020 Sep;146(9):2435-2438. doi: 10.1007/s00432-020-03137-6. Epub 2020 Feb 6.
Abstract
摘要
相似文献
1
MYC/BCL2/BCL6 triple hit lymphoma of the pericardium: a case report and review of the literature.心包的MYC/BCL2/BCL6三打击淋巴瘤：一例病例报告及文献复习
J Cancer Res Clin Oncol. 2020 Sep;146(9):2435-2438. doi: 10.1007/s00432-020-03137-6. Epub 2020 Feb 6.
2
Double-hit lymphoma: So what?双打击淋巴瘤：那又怎样？
Hematol Oncol. 2019 Jun;37 Suppl 1:19-23. doi: 10.1002/hon.2581.
3
MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas.三打击淋巴瘤中的 MYC/BCL2/BCL6：40 例患者的研究，并与 MYC/BCL2 和 MYC/BCL6 双打击淋巴瘤进行比较。
Mod Pathol. 2018 Sep;31(9):1470-1478. doi: 10.1038/s41379-018-0067-x. Epub 2018 May 21.
4
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma.弥漫性大 B 细胞淋巴瘤中 MYC、BCL2 和/或 BCL6 额外拷贝的预后影响：与双/三打击淋巴瘤和双表达淋巴瘤的比较。
Diagn Pathol. 2019 Jul 17;14(1):81. doi: 10.1186/s13000-019-0856-7.
5
Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.一位患有伴有MYC、BCL6和BCL2基因座异常的高级别B细胞淋巴瘤患者出现意外良好转归。
Cancer Genet. 2018 Apr;222-223:25-31. doi: 10.1016/j.cancergen.2018.01.003. Epub 2018 Feb 3.
6
Clinical significance of 'double-hit' and 'double-expression' lymphomas.“双打击”和“双表达”淋巴瘤的临床意义。
J Clin Pathol. 2020 Mar;73(3):126-138. doi: 10.1136/jclinpath-2019-206199. Epub 2019 Oct 15.
7
Quadruple-hit pleomorphic mantle cell lymphoma with MYC, BCL2, BCL6, and CCND1 gene rearrangements.伴有MYC、BCL2、BCL6和CCND1基因重排的四重打击多形性套细胞淋巴瘤
Br J Haematol. 2021 Nov;195(4):634-637. doi: 10.1111/bjh.17729. Epub 2021 Sep 16.
8
[The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].[涉及c-MYC/8q24、BCL2/18q21和/或BCL6/3q27基因的易位在滤泡性淋巴瘤患者中的作用。单中心数据的回顾性分析]
Ter Arkh. 2019 Jul 15;91(7):52-62. doi: 10.26442/00403660.2019.07.000070.
9
Clinical Significance of , C-, and Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.弥漫性大 B 细胞淋巴瘤中 、 、 和遗传异常、Epstein-Barr 病毒感染、CD5 蛋白表达、生发中心 B 细胞/非生发中心 B 细胞亚型、MYC/BCL2 蛋白共表达和 MYC/BCL2/BCL6 蛋白共表达的临床意义：120 例患者的临床与病理相关性研究。
Int J Med Sci. 2019 Apr 20;16(4):556-566. doi: 10.7150/ijms.27610. eCollection 2019.
10
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.MYC和BCL6同时重排及表达对初发弥漫性大B细胞淋巴瘤的预后影响
Oncotarget. 2016 Jan 19;7(3):2401-16. doi: 10.18632/oncotarget.6262.
本文引用的文献
1
Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma.临床惰性原发性人疱疹病毒8型阴性渗出液淋巴瘤中的侵袭性基因组特征。
Blood. 2019 Jan 24;133(4):377-380. doi: 10.1182/blood-2017-12-822171. Epub 2018 Dec 3.
2
MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas.三打击淋巴瘤中的 MYC/BCL2/BCL6：40 例患者的研究，并与 MYC/BCL2 和 MYC/BCL6 双打击淋巴瘤进行比较。
Mod Pathol. 2018 Sep;31(9):1470-1478. doi: 10.1038/s41379-018-0067-x. Epub 2018 May 21.
3
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.首次达到完全缓解的双打击淋巴瘤患者的预后。
J Clin Oncol. 2017 Jul 10;35(20):2260-2267. doi: 10.1200/JCO.2017.72.2157. Epub 2017 May 5.
4
Cardiac non-Hodgkin's lymphoma: clinical characteristics and trends in survival.心脏非霍奇金淋巴瘤：临床特征与生存趋势
Eur J Haematol. 2016 Nov;97(5):445-452. doi: 10.1111/ejh.12751. Epub 2016 Mar 30.
5
2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).2015年欧洲心脏病学会（ESC）心包疾病诊断和管理指南：欧洲心脏病学会（ESC）心包疾病诊断和管理工作组 认可机构：欧洲心胸外科学会（EACTS）
Eur Heart J. 2015 Nov 7;36(42):2921-2964. doi: 10.1093/eurheartj/ehv318. Epub 2015 Aug 29.
6
Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.一线、剂量递增的免疫化疗与双打击淋巴瘤患者显著的无进展生存优势相关：系统评价和荟萃分析。
Br J Haematol. 2015 Aug;170(4):504-14. doi: 10.1111/bjh.13463. Epub 2015 Apr 24.
7
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.双打击淋巴瘤中诱导方案和干细胞移植对结局的影响：一项多中心回顾性分析。
Blood. 2014 Oct 9;124(15):2354-61. doi: 10.1182/blood-2014-05-578963. Epub 2014 Aug 26.
8
Symptomatic pericardial effusion in Hodgkin's lymphoma: a rare occurrence. Case report and review of the literature.霍奇金淋巴瘤中的症状性心包积液：罕见病例。病例报告及文献综述
Tumori. 2012 Mar-Apr;98(2):50e-52e. doi: 10.1700/1088.11949.
9
Primary cardiac lymphoma: an analysis of presentation, treatment, and outcome patterns.原发性心脏淋巴瘤：临床表现、治疗和预后模式分析。
Cancer. 2011 Feb 1;117(3):581-9. doi: 10.1002/cncr.25444. Epub 2010 Oct 4.
10
Extranodal lymphoma.结外淋巴瘤
Arch Pathol Lab Med. 2008 Apr;132(4):565-78. doi: 10.5858/2008-132-565-EL.
Zotero 插件